Sage Journals: Discover world-class research

Retricted access

Review article

First published 2014-4

Dabrafenib Therapy for Advanced Melanoma

Van Anh Trinh, Jennifer E. Davis, Jaime E. Anderson [...]

Annals of Pharmacotherapy

Retricted access

Review article

First published 2014-11

Controversies in the Management of Advanced Melanoma

Anthony Jarkowski, LeAnn Norris, Van Anh Trinh

Annals of Pharmacotherapy

Retricted access

Research article

First published 2020-09

Acquired Secondary RAS Mutation in BRAF V600E -Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors

Maria E. Cabanillas, Ramona Dadu, Pryianka Iyer [...]

Thyroid®

Free access

Research article

First published 2012-3

The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence

Charlotte Lemech, Jeffrey Infante, Hendrik-Tobias Arkenau

Therapeutic Advances in Medical Oncology

Retricted access

Case report

First published 2020-10

Treatment exceeds expectations with vemurafenib monotherapy in a patient with BRAF V600E -mutant metastatic melanoma

Mesut Yilmaz, Şermin Güven Meşe

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2012

Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities

Charlotte Lemech, Hendrik-Tobias Arkenau

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2017-1

Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib

Jean-Philip Lacroix, Beatrice Wang

Journal of Cutaneous Medicine and Surgery

Retricted access

Research article

First published 2013-10

Clinical Responses to Vemurafenib in Patients with Metastatic Papillary Thyroid Cancer Harboring BRAF V600E Mutation

Kevin B. Kim, Maria E. Cabanillas, Alexander J. Lazar [...]

Thyroid®

Open access

Case report

First published 2021

A case of advanced adenocarcinoma genetically confirmed with EGFR/BRAF co-mutation in both primary and metastatic lesions

Kei Morikawa, Masahiro Iinuma, Yusuke Shinozaki [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2019-11

Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol

Amir Iravani, Benjamin Solomon, David A. Pattison [...]

Thyroid®

Search results